DGAP-News: MorphoSys and Incyte Announce Swissmedic Temporary Approval of Minjuvi(R) (tafasitamab) in Combination with Lenalidomide for the Treatment of Adults with r/r DLBCL Seite 1

22.03.2022 - DGAP-News: MorphoSys AG / Key word(s): Miscellaneous MorphoSys and Incyte Announce Swissmedic Temporary Approval of Minjuvi(R) (tafasitamab) in Combination with Lenalidomide for the Treatment of Adults with r/r DLBCL 22.03.2022 / 21:01 The issuer ... Seite 1

Related Keywords

Germany ,Morges ,Switzerland General ,Switzerland ,Planegg ,Bayern ,Swiss ,Jonathan Dickinson ,Mike Akimov ,Incyte Europe ,Head Of Global Drug Development ,Nasdaq ,Incyte Announce Swissmedic Temporary Approval ,Diffuse Largeb Cell ,Executive Vice President ,General Manager ,Global Drug Development ,Morphosys ,Gap News ,